The Stephen F. Martin Research Group

                      
STEPHEN F. MARTIN (.doc)
   
                   Personal
  Born Albuquerque, NM Date 8 February 1946
  Marital Status Married
                   Residence
  5316 Tortuga Trail
  Austin, TX 78731
  (512) 451-2314
                   Business
  Dept. of Chemistry and Biochemistry
  The University of Texas at Austin
  Austin, TX 78712
  (512) 471-3915 (voice)
  (512) 471-4180 (FAX)
                     Education
         
University of New Mexico (BS, 1968); undergraduate research with Prof. R. N. Castle  
  Princeton University (MA, 1970; PhD, 1972) with Prof. E. C. Taylor
  Institute of Organic Chemistry, University of Munich (1972-73) with R. Gompper
  Massachusetts Institute of Technology (1973-74) with G. Büchi
                     Employment
  University of Texas; Assist. Professor (1974-80);
Assoc. Professor (1980-86); Professor (1986-)
                    Selected Honors and Awards
  Harold W. Dodds Fellow, Princeton University, 1971-72
  Alexander von Humboldt Stipendiat, University of Munich, 1972-73
  National Institutes of Health Postdoctoral Fellow, MIT, 1973-74
  National Institutes of Health Research Career Development Award 1980-85
  American Cyanamide Academic Awardee, 1986
  Rowland Pettit Centennial Professor of Chemistry, 1992-2000
  Alexander von Humboldt Prize, 1995-1997
  Arthur C. Cope Scholar Award, 1996
  Novartis Chemistry Award, 1997
  Ta-Shue Chou Foundation Award (Academica Sinica), 2000
  M. June and J. Virgil Waggoner Regents Chair of Chemistry, 2000-present
  Japan Society for the Promotion of Science Award, 2001
  Wyeth Research Award, 2003
  Fellow of American Association for the Advancement of Science 2005-
                      Selected Other Professional Recognition  
  NIH Medicinal Chemistry Study Section, 1983-87
  Symposium Executive Officer for 31st National Organic Symposium, 1989
  Member of Editorial Advisory Board of "Progress in Heterocyclic Chemistry", 1988-1996
  Visiting Professor, University of Paris VI, Fall 1990
  Visiting Professor, National Taiwan University, Spring 1991  
  Member of Board of Editors, Organic Synthesis, 1991-1999  
  Member of Advisory Board, Organic Synthesis, 1999-present  
  Member Advisory Board of International Society of Heterocyclic Chemistry, 1992-1994  
  Consultant, Procter and Gamble, 1992-1998  
  Consultant, Elan Pharmaceutical (formerly Athena Neurosciences), 1992-2005
  Regional Editor of Tetrahedron, 1992-present
  Executive Board of Editors of Tetrahedron Publications, 1992-present
  Executive Committee, Division of Organic Chemistry ACS, 1998-2000  
  Visiting Professor, University of Versailles, June, 1999
  Consultant for Abbott Laboratories, 2000-2005
  Member International Organizing Committee for International Conference on Organic Synthesis–16
  Fellow of Institute of Cellular and Molecular Biology, University of Texas, 2003-2004
  Visiting Professor, University of Bordeaux, June, 2004
  Consultant ICOS Corporation, 2003-present
  Chair, Department of Chemistry and Biochemistry, 2004-present
  Adjunct Professor, UTMB School of Medicine 2005-
                      Memberships  
  Honorary Societies- Phi Beta Kappa, Phi Kappa Phi, Kappa Mu Epsilon, and Sigma Xi
  Professional Societies- American Chemical Society, Royal Society of Chemistry (London)
 
 
                      Present Research Interests
 

The main thrust of current research is directed toward the syntheses of natural and unnatural products that are of biological or structural interest. These investigations focus upon the design and development of general strategies that may be employed to assemble molecular subunits common to a number of alkaloids, terpenes, and acetogenins. A variety of new methods for effecting the regio- and stereoselective formation of carbon-carbon bonds as well as for the introduction and manipulation of functional groups are being explored. 

 
 
In the area of alkaloid synthesis, we are developing and applying new tactics for constructing nitrogen heterocycles. Some problems of current interest involve the use of Diels-Alder and hetero Diels-Alder cycloadditions, dipolar cycloadditions, vinylogous Mannich reactions and other transformations of iminium ions, and ring closing metathesis as key steps to construct heterocyclic subunits common to different families of alkaloids. Some specific targets of interest include the lundurines, methyl lysergate, pinnamine, asparagamine, sarain A, hederacine A, actinophyllic acid, citrinadin A, haouamine A, acutumine, sieboldine A, carteramine A, and the welwitindolinones. The asymmetric syntheses of oxygenated natural products, especially C-aryl glycosides and glycoepitope mimetics, constitutes another important area of our research program.  A new and general strategy for constructing C-aryl glycosides has been developed and is being applied to the total syntheses of pluramycin, kidamycin, 5-hydroxyaloin A, and medermycin.  Other natural compounds of interest include the cortistatins and IB-00208. These targets have inspired novel variants of [4+3] cycloadditions and a new entry to angular polyaromatic systems. We have discovered a rhodium catalyst that complements the reactivity and selectivity of other known catalysts in allylic alkylations, and we are now exploring its use in cyclizations and a variety of cascade reactions to rapidly construct complex molecular architectures. Toward developing novel strategies for diversity oriented synthesis, we are developing four component reactions to prepare intermediates that may be readily elaborated in several facile steps to generate molecules having diverse heterocyclic scaffolds and functionality.
 
 

In a more biological arena, we are exploring the effects of preorganizing and varying the hydrophobicity of ligands upon protein-ligand interactions. It is commonly assumed that preorganizing a flexible ligand in the three dimensional shape it adopts when bound to a macromolecular receptor will provide a derivative having an increased binding affinity, primarily because the rigidified molecule is expected to benefit from a lesser entropic penalty. Over the years we have introduced conformational constraints into peptide-like ligands and never observed the increased binding affinities that were expected based upon the number of rotors being restricted. In order to understand the molecular basis of these observations, we began a series of detailed structural and energetic studies of complexes formed between constrained and flexible phosphotyrosine-derived pseudopeptides and selected SH2 domains. Contrary to the conventional wisdom, we discovered that the entropies of binding of preorganized ligands may be disfavored relative to less potent, flexible controls. We have also observed that energetic effects associated with changes in ligand hydrophobicity are not purely entropic and do not necessarily vary predictably.  These remarkable findings mandate reconsideration of current thinking about the effects of ligand preorganization in protein-ligand interactions, but more data are needed before new paradigms for the structure based design of biologically potent ligands can be formulated. Toward this goal, we are embarking on a more general study of the detailed effects of ligand preorganization and hydrophobicity upon energetics, kinetics, structure and dynamics in protein-ligand interactions.